RNA sequencing reveals that KLK3 (PSA) and other transcriptional target genes of AR are significantly downregulated upon VNPP433-3β treatment besides inhibiting transcription of several genes in pathways critical for prostate cancer progression in prostate cancer cells. The gene discussed is KLK3; the disease is prostate carcinoma.